The Role of Smoking in Periodontal Status (TRSPS)

December 8, 2025 updated by: Tuğba ŞAHİN

The Role of Smoking Habits in Periodontal Health and Disease: A Cross-Sectional Study

484 patients were asked whether they currently smoked and whether they had smoked 100 or more cigarettes during their lifetime. Based on this information, they were divided into two groups: current smokers (test group, n=242) and non-smokers (control group, n=242). Current smokers were defined as individuals who had smoked ≥100 cigarettes in their lifetime and continued smoking. In contrast, non-smokers included individuals who had smoked fewer than 100 cigarettes in their lifetime and were not currently smoking. Participants were also asked about the number of cigarettes smoked per day and the duration of smoking in years, and pack-years were calculated accordingly. Plaque index, gingival index, probing depth, bleeding on probing, gingival recession, and attachment loss were evaluated for both groups. Periodontal health status (Periodontal health, gingivitis, and periodontitis) was assessed by one clinician applying the 2017 World Workshop on Classifying Periodontal and Peri-Implant Diseases and Conditions and the 2023 European Federation of Periodontology's Guidelines. Patients with periodontitis were classified according to stage and grade. This measurement was obtained via a calibrated UNC-15 periodontal probe at each tooth.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

484 patients were asked whether they currently smoked and had smoked 100 or more cigarettes during their lifetime. Based on this information, they were divided into two groups: current smokers (test group, n=242) and non-smokers (control group, n=242). Current smokers were defined as individuals who had smoked ≥100 cigarettes in their lifetime and continued smoking. In contrast, non-smokers included individuals who had smoked fewer than 100 cigarettes in their lifetime and were not currently smoking. Participants were also asked about the number of cigarettes smoked per day and the duration of smoking in years, and pack-years were calculated accordingly. Plaque index, gingival index, probing depth, bleeding on probing, gingival recession, and attachment loss were evaluated for both groups. Periodontal health status (Periodontal health, gingivitis, and periodontitis) was assessed by one clinician applying the 2017 World Workshop on Classifying Periodontal and Peri-Implant Diseases and Conditions and the 2023 European Federation of Periodontology's Guidelines. Patients with periodontitis were classified according to stage and grade. This measurement was obtained via a calibrated UNC-15 periodontal probe at each tooth.

Study Type

Observational

Enrollment (Actual)

484

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bolu, Turkey (Türkiye), 14030
        • Bolu Abant Izzet Baysal University, Dentistry Faculty

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study includes patients who are smokers and those who are non-smokers.

Description

Inclusion Criteria:

  • Age 18 years or older
  • No systemic diseases that could affect periodontal or general health
  • No history of periodontal treatment within the past six months
  • For the non-smoker group: abstinence from smoking for at least five years

Exclusion Criteria:

  • Use of antibiotics or anti-inflammatory drugs
  • Pregnant or lactating women
  • Diabetes mellitus
  • Use of waterpipe or chewing tobacco (for the smoker group)
  • Individuals undergoing chemotherapy or radiotherapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Smoker
Current smokers were defined as individuals who had smoked ≥100 cigarettes in their lifetime and continued smoking.
The patient's daily cigarette consumption, duration of smoking, and pack-years were evaluated.
Other Names:
  • Smoking
Non-smoker
Non-smokers included individuals who had smoked fewer than 100 cigarettes in their lifetime and were not currently smoking.
The patient's daily cigarette consumption, duration of smoking, and pack-years were evaluated.
Other Names:
  • Smoking

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
periodontal pocket depth
Time Frame: Baseline
Periodontal pocket depth measured in millimeters using a Williams periodontal probe. The distance from the gingival margin to the bottom of the periodontal pocket was recorded at each site.
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
bleeding on probing
Time Frame: Baseline
Bleeding on probing assessed using a periodontal probe. After gently inserting the probe into the gingival sulcus and moving it laterally along the pocket wall, bleeding was recorded as present (+) or absent (-).pocket and gently moved laterally along the pocket wall. + is maximum and - is minimum.
Baseline
plaque index
Time Frame: Baseline
Oral hygiene status assessed using the Plaque Index, which measures dental plaque accumulation adjacent to the gingival margin. Scores range from 0 (no plaque) to 3 (abundant plaque), with higher scores indicating poorer oral hygiene.
Baseline
gingival index
Time Frame: Baseline
Gingival inflammation assessed using the Löe and Silness Gingival Index. Each site was scored on a 0-3 scale, where 0 = normal gingiva and 3 = severe inflammation with edema, redness, and spontaneous bleeding. Higher scores indicate worsening gingival inflammation.
Baseline
clinical attachment level
Time Frame: Baseline
Clinical attachment level measured in millimeters using a periodontal probe. CAL was calculated as the distance from the cementoenamel junction to the bottom of the periodontal pocket and used to assess periodontal tissue support loss.
Baseline
Daily cigarette
Time Frame: Baseline
It includes the number of cigarettes smoked per day. Self-reported number of cigarettes smoked per day.
Baseline
Smoking Duration
Time Frame: Baseline
Self-reported duration of smoking, recorded as the number of years the participant has smoked.
Baseline
Pack-years
Time Frame: Baseline
Smoking exposure calculated as pack-years, defined as the number of cigarettes smoked per day divided by 20 and multiplied by the number of years of smoking.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: TUGBA SAHIN, Abant Izzet Baysal University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 2, 2025

Primary Completion (Actual)

September 15, 2025

Study Completion (Actual)

October 2, 2025

Study Registration Dates

First Submitted

November 18, 2025

First Submitted That Met QC Criteria

December 8, 2025

First Posted (Actual)

December 22, 2025

Study Record Updates

Last Update Posted (Actual)

December 22, 2025

Last Update Submitted That Met QC Criteria

December 8, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontal Diseases

Clinical Trials on Intervention

Subscribe